Deutsche Beteiligungs AG (XSWX:DBAN)
CHF 21.75 (0%) Market Cap: 372.24 Mil Enterprise Value: 491.34 Mil PE Ratio: 0 PB Ratio: 0.66 GF Score: 60/100

Q1 2026 Deutsche Beteiligungs AG Earnings Call Transcript

May 7, 2026 / 10:59 AM GMT
Release Date Price: CHF23.25

Key Points

Positve
  • Deutsche Beteiligungs AG (XTER:DBAN) successfully sold Craft & Bauer, transitioning it from an automotive supplier to a medtech supplier, showcasing strategic adaptability.
  • The company completed seven transactions in the last eight months, including four acquisitions and three exits, demonstrating active portfolio management.
  • Deutsche Beteiligungs AG (XTER:DBAN) deployed over $500 million in enterprise value through bilateral transactions, indicating strong market trust and brand reputation.
  • The company maintained a stable NAV and confirmed its guidance despite a challenging quarter, reflecting resilience in volatile market conditions.
  • The investment in HIP is off to a strong start, with growth potential in the medtech, defense, and robotics sectors, providing diversification and optionality.
Negative
  • The company reported a negative group income of 20 million euros, primarily due to fluctuations in peer group valuations.
  • A high concentration of 37% in the top five portfolio companies raises concerns about diversification risks.
  • The first quarter was weaker than expected, impacted by stock market volatility and an unfavorable cutoff date for earnings.
  • The company's portfolio value decreased due to disposals and valuation changes, affecting overall financial performance.
  • The delay in Fund 9 by two years has impacted earnings, although mitigated by other factors.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DBANn.DE - Deutsche Beteiligungs AG
Q1 2026 Deutsche Beteiligungs AG Earnings Call
May 07, 2026 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Yes, hello and a warm welcome on our side.

Jumping straight into what was already an active start to the year. Obviously, there's a lot of volatility out there, and we'll come to that later.

But despite all the fog and mist, we were able to sell Craft & Bauer, a company which we have accompanied for seven years.

The company has transitioned from being mainly a supplier to the automotive industry to be. Come mainly a supplier to the medtech company. And one thing leads to another. Mr. Bauer from Kraft & Bauer was one of the very close friends over time from Marcus Hip of Hip Technology. And so he introduced us to Marcus Hip. And that led to a very nice investment in the medtech space.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot